highli
flexibl
genom
influenza
virus
caus
annual
epidem
sometim
pandem
around
world
nearli
year
influenza
virus
global
threat
human
pales
base
antigen
hemagglutinin
ha
protein
influenza
virus
classifi
two
group
least
differ
subtyp
ha
protein
function
protein
mediat
entri
influenza
virus
suscept
host
cell
thu
contain
variou
epitop
recogn
neutral
antibodi
skehel
wiley
howev
heterosubtyp
neutral
protect
antibodi
respons
rare
observ
gener
popul
larg
high
mutat
rate
ha
protein
especi
globular
head
region
primari
target
humor
immun
respons
consequ
new
reassort
influenza
viru
emerg
human
immun
system
previous
encount
pandem
may
occur
swineorigin
influenza
exampl
pandem
pandem
influenza
viru
contain
gene
segment
american
eurasia
swine
genet
linkag
garten
et
al
nucleotid
sequenc
align
shown
ha
sequenc
pandem
influenza
viru
diverg
sequenc
season
influenza
virus
previous
content
list
avail
scivers
sciencedirect
journal
homepag
wwwelseviercomlocateyviro
virolog
circul
human
antigen
ha
strain
also
highli
distinct
previous
circul
influenza
virus
garten
et
al
hancock
et
al
peopl
especi
young
peopl
gener
lack
protect
new
viru
hancock
et
al
pandem
influenza
vaccin
proven
effect
induc
neutral
antibodi
respons
pandem
influenza
viru
liang
et
al
zhu
et
al
import
determin
whether
crossreact
neutral
antibodi
season
pandem
influenza
virus
present
individu
infect
vaccin
pandem
influenza
recent
wrammert
et
al
discov
plasmablast
pandem
influenza
patient
produc
crosssubtyp
neutral
antibodi
target
ha
stalk
head
domain
wrammert
et
al
examin
whether
antibodi
exist
individu
vaccin
pandem
influenza
studi
use
fulllength
ha
protein
pandem
influenza
viru
rais
fulli
human
neutral
mab
obtain
monoclon
antibodi
memori
b
cell
pandem
influenza
vaccin
recipi
confirm
monoclon
antibodi
recogn
lysat
pandem
viru
recent
circul
season
influenza
viru
seven
human
monoclon
antibodi
found
appar
neutral
effect
differ
subtyp
influenza
virus
includ
virus
belong
group
group
pandem
influenza
viru
interestingli
found
monoclon
antibodi
includ
seven
neutral
mab
bound
ha
stem
region
rel
conserv
among
differ
influenza
viru
strain
find
indic
broad
crosssubtyp
neutral
antibodi
respons
target
ha
stem
region
exist
individu
vaccin
pandem
influenza
broadli
reactiv
memori
b
cell
may
import
protect
human
infect
differ
influenza
virus
function
analysi
reveal
region
contain
sever
least
four
conserv
neutral
epitop
could
recogn
rais
mab
experi
show
one
linear
epitop
fieggwtgmvdgwygyhh
region
fusion
peptid
result
may
help
design
univers
influenza
vaccin
healthi
femal
adult
volunt
vaccin
pandem
influenza
splitvirion
vaccin
one
month
enrol
studi
use
flow
cytometri
separ
pandem
haspecif
memori
b
cell
three
surfac
marker
igg
haspecif
bcr
baculovirusexpress
ha
protein
use
cell
sort
shown
fig
memori
b
cell
account
approxim
total
peripher
blood
small
lymphocyt
less
select
memori
b
cell
haspecif
antibodi
variabl
gene
memori
b
cell
identifi
singlecel
rtpcr
nest
pcr
wrammert
et
al
nineteen
human
monoclon
antibodi
construct
use
k
framework
obtain
bound
ha
protein
fig
mab
use
differ
v
j
gene
segment
heavi
light
chain
variabl
gene
v
j
usag
present
detail
tabl
presenc
somat
mutat
mab
reveal
b
cell
produc
mab
germin
center
notabl
five
mab
use
gene
use
gene
consid
nonexclus
characterist
heterosubtyp
bind
ha
stem
region
neutral
effect
ekiert
et
al
sui
et
al
five
mab
use
differ
dh
vl
jl
gene
indic
differ
b
cell
clone
experi
show
ha
protein
denatur
heat
four
mab
fulli
maintain
bind
abil
antigen
one
mab
complet
lost
bind
abil
antigen
rest
mab
partial
retain
bind
abil
ha
protein
fig
mab
bound
season
influenza
viru
lysat
pandem
influenza
viru
lysat
bind
avid
differ
fig
insect
cellexpress
domain
protein
pandem
influenza
viru
also
use
analyz
bind
activ
mab
shown
fig
one
mab
exhibit
bind
activ
domain
wherea
mab
bind
result
suggest
mab
may
bind
domain
result
indic
memori
b
cell
peopl
vaccin
pandem
influenza
vaccin
secret
antibodi
primarili
target
region
antibodi
crossreact
season
influenza
viru
investig
neutral
effect
fulli
human
mab
microneutr
assay
adopt
screen
mab
neutral
activ
experi
demonstr
seven
mab
show
rel
higher
neutral
activ
pandem
influenza
viru
ic
seven
neutral
mab
pandem
influenza
viru
mgml
less
tabl
ic
mab
mgml
data
shown
interestingli
seven
mab
also
show
neutral
activ
sever
influenza
viru
strain
includ
subtyp
fig
tabl
sequenc
analysi
reveal
three
mab
use
gene
one
mab
use
gene
tabl
next
analyz
neutral
mechan
broad
neutral
mab
cellcel
fusion
experi
adopt
result
show
seven
broad
neutral
mab
exhibit
appar
inhibit
activ
syncytia
format
cell
transfect
ha
express
plasmid
fig
probabl
indic
mab
took
effect
viruscel
membran
fusion
phase
hinder
function
broad
neutral
effect
probabl
result
rel
conserv
map
epitop
recogn
test
mab
competit
elisa
use
fig
show
use
vh
vl
gene
bound
ha
site
consist
sequenc
analysi
result
tabl
deriv
differ
variabl
gene
recogn
epitop
shown
fig
neutral
epitop
recogn
linear
wherea
epitop
recogn
complet
conform
two
neutral
epitop
recogn
respect
partial
conform
epitop
result
reveal
region
contain
sever
least
four
conserv
neutral
epitop
coexist
differ
strain
influenza
viru
confirm
whether
select
neutral
mab
capabl
bind
seri
synthet
peptid
ha
cover
entir
region
tenaminoacid
overlap
use
detect
bind
site
seven
mab
tabl
shown
fig
could
specif
recogn
peptid
fieggwtgmvdgwygyhh
elisa
assay
locat
fusion
peptid
believ
conserv
among
differ
strain
influenza
virus
skehel
wiley
sequenc
align
show
amino
acid
residu
linear
epitop
conserv
among
test
virus
differ
subtyp
fig
conserv
amino
acid
residu
may
play
critic
role
recognit
epitop
crosssubtyp
neutral
mab
base
observ
conclud
recogn
linear
epitop
fusion
peptid
region
mab
show
signific
reaction
peptid
suggest
target
conform
epitop
analyz
complex
ha
protein
togeth
mab
use
structur
biolog
method
reveal
characterist
epitop
recogn
mab
studi
demonstr
memori
b
cell
secret
broadli
neutral
heterosubtyp
antibodi
target
present
recipi
pandem
influenza
vaccin
corti
et
al
report
crosssubtyp
neutral
mab
immort
b
cell
rais
individu
vaccin
season
influenza
confirm
almost
heterosubtyp
mab
recogn
epitop
within
ha
stem
region
corti
et
al
result
line
observ
corti
et
al
wrammert
et
al
show
broadli
reactiv
crosssubtyp
neutral
antibodi
respons
induc
influenza
viru
infect
patient
individu
accept
vaccin
pandem
season
influenza
virus
influenza
ha
stem
region
crucial
recognit
broadli
neutral
crosssubtyp
antibodi
region
promis
target
crosssubtyp
influenza
vaccin
contain
linear
bcell
neutral
epitop
sever
conform
one
shown
studi
importantli
fusion
peptid
critic
target
bind
broad
neutral
mab
believ
studi
broad
neutral
monoclon
antibodi
would
benefici
develop
broadli
effect
heterosubtyp
influenza
vaccin
gener
seven
neutral
monoclon
antibodi
studi
interest
note
partial
v
gene
differ
influenc
neutral
activ
without
chang
bind
activ
exampl
mab
show
similar
antigenbind
differ
neutral
activ
reason
may
neutral
mab
target
postadhes
phase
interf
function
viruscel
membran
fusion
process
bind
activ
alon
may
suffici
prevent
viral
entri
suscept
cell
addit
use
complet
differ
vh
gene
recogn
site
region
work
also
indic
broadli
reactiv
human
neutral
monoclon
antibodi
obtain
studi
may
potenti
use
treatment
sever
case
influenza
viru
infect
hung
et
al
sever
neutral
monoclon
antibodi
target
differ
epitop
use
cocktail
cover
mani
influenza
subtyp
possibl
far
mani
neutral
mab
target
ha
stem
region
gener
care
studi
antibodi
incomplet
enumer
tabl
inform
obtain
use
design
broadli
protect
influenza
vaccin
nevertheless
antigen
charact
ha
stem
region
complic
includ
fusion
peptid
number
linear
conform
neutral
epitop
within
region
therefor
research
need
obtain
deeper
comprehens
understand
interact
neutral
antibodi
ha
stem
region
minim
interfer
nonneutr
antibodi
aid
success
develop
heterosubtyp
broadli
protect
influenza
vaccin
singlecel
rtpcr
rapid
method
product
fulli
human
neutral
monoclon
antibodi
igg
haspecif
bcr
marker
use
work
suitabl
select
antigenspecif
memori
b
cell
screen
strategi
significantli
increas
effici
obtain
highaffin
antigenspecif
human
monoclon
antibodi
platform
establish
studi
appli
develop
fulli
human
mab
target
infecti
agent
hiv
hcv
hbv
studi
approv
biomed
research
ethic
committe
shanghai
institut
biolog
scienc
ca
healthi
femal
adult
receiv
pandem
influenza
vaccin
recruit
studi
influenza
viru
strain
use
studi
follow
refer
ajiangxidonghu
refer
refer
kindli
provid
prof
yuelong
shu
chines
center
diseas
control
prevent
competit
elisa
detect
bind
epitop
seven
neutral
mab
percentag
competit
two
mab
elisa
bind
assay
shown
percentag
competit
calcul
reduct
absorb
mab
bind
competit
occur
shadow
grid
complet
competit
percentag
competit
four
neutral
epitop
vertic
row
nonconjug
mab
horizont
row
biotinconjug
mab
four
basic
amino
acid
residu
ha
cleavag
site
remov
confirm
nonpathogen
mammalian
ferret
avian
chicken
host
subtyp
viru
lysat
use
studi
pandem
splitviru
vaccin
ha
strain
trival
season
influenza
vaccin
ha
strain
vaccin
produc
hualan
biolog
bacterin
compani
china
ha
gene
synthes
generay
china
sequenc
influenza
strain
fulllength
ha
subdomain
aa
express
use
bactobac
baculoviru
express
system
invitrogen
accord
manufactur
protocol
ha
purifi
accord
previous
describ
method
wang
et
al
ctermin
fusion
human
igg
fc
tag
purifi
use
protein
g
sepharos
fast
flow
column
ge
accord
manufactur
instruct
venou
blood
collect
volunt
tube
contain
sodium
citrat
anticoagul
lymphocyt
monocyt
prepar
use
densiti
separ
medium
lympholytesh
cedarlan
accord
manufactur
instruct
singlecel
sort
perform
use
aria
ii
bd
cell
sorter
fitclabel
mous
antihuman
antibodi
apclabel
mous
antihuman
igg
antibodi
purchas
bd
conjug
purchas
sigmaaldrich
ha
protein
label
biotin
use
ezlink
sulfonhslcbiotin
biotinyl
reagent
thermo
scientif
accord
manufactur
instruct
haspecif
memori
b
cell
gate
isol
igg
haspecif
bcr
cell
flow
cytometri
data
analyz
flowjo
softwar
gener
human
monoclon
antibodi
perform
use
singlecel
rtpcr
previous
describ
wrammert
et
al
briefli
haspecif
memori
b
cell
sort
pcr
plate
contain
rnase
inhibitor
promega
one
cell
per
well
antibodi
variabl
gene
vh
vk
amplifi
cell
rtpcr
nest
pcr
use
panel
primer
previous
describ
restrict
site
incorpor
pcr
specif
primer
design
accord
characterist
v
j
gene
famili
amplifi
gene
belong
vh
vk
gene
clone
igg
igk
express
vector
respect
igg
igk
express
plasmid
cotransfect
cell
use
lipofectamin
transfect
reagent
invitrogen
accord
manufactur
instruct
supernat
harvest
human
monoclon
antibodi
purifi
use
rmp
protein
sepharos
fast
flow
column
ge
accord
manufactur
instruct
ninetysix
microwel
plate
nunc
coat
viral
lysat
recombin
protein
concentr
mgml
sodium
carbonatebicarbon
buffer
ph
c
overnight
phosphatebuff
salin
pb
ph
contain
bovin
serum
albumin
use
block
dilut
buffer
block
two
hour
plate
wash
human
monoclon
antibodi
ad
plate
incub
anoth
two
hour
next
horseradish
peroxidaseconjug
goat
antihuman
igg
fcspecif
antibodi
sigmaaldrich
ad
plate
incub
one
hour
tetramethylbenzidin
sigmaaldrich
use
substrat
optic
densiti
measur
nm
od
nm
microwel
plate
autoread
thermo
scientif
peptid
elisa
overlap
peptid
tabl
design
accord
protein
sequenc
pandem
influenza
viru
strain
peptid
ntermin
biotinyl
puriti
synthes
shanghai
scienc
peptid
china
streptavidin
coat
onto
plate
nunc
mgml
sodium
carbonatebicarbon
buffer
ph
overnight
wash
unbound
streptavidin
block
two
hour
overlap
peptid
ad
mgml
incub
anoth
one
hour
thereaft
procedur
mention
ha
protein
use
coat
plate
nunc
human
monoclon
antibodi
label
biotin
use
ezlink
sulfonhslcbiotin
biotinyl
reagent
thermo
scientif
accord
manufactur
instruct
block
two
hour
excess
amount
human
monoclon
antibodi
conjug
biotin
ad
plate
plate
incub
two
hour
biotinlabel
monoclon
antibodi
ad
plate
plate
incub
anoth
two
hour
next
streptavidinhorseradish
peroxidas
conjug
bd
ad
plate
incub
one
hour
tetramethylbenzidin
sigmaaldrich
use
substrat
optic
densiti
measur
nm
od
nm
microwel
plate
autoread
thermo
scientif
percentag
competit
calcul
reduct
absorb
mab
bind
competit
occur
experi
perform
gener
previous
describ
godley
et
al
goto
kawaoka
prabhu
et
al
briefli
cell
atcc
transfect
invitrogen
plasmid
express
pandem
protein
sequenc
cell
cultur
plate
transfect
plasmid
use
lipofectamin
transfect
reagent
invitrogen
h
transfect
cell
treat
tosylsulfonyl
phenylalanyl
chloromethyl
keton
trypsin
mgml
min
order
cleav
cell
incub
min
mab
mgml
afterward
cell
wash
pb
ph
decreas
min
next
cell
incub
mab
concentr
mgml
complet
medium
h
cell
fix
wtvol
paraformaldehyd
stain
wtvol
toluidin
blue
pb
result
observ
optic
microscop
photograph
microneutr
assay
perform
previous
describ
row
et
al
briefli
antibodi
serial
dilut
twofold
ml
mix
influenza
viru
tcid
ml
per
well
positivecontrol
well
viru
negativecontrol
well
without
viru
includ
plate
twohour
incub
co
humidifi
atmospher
ml
trypsinedta
suspend
mdck
cell
ml
ad
well
plate
incub
h
co
humidifi
atmospher
cell
monolay
wash
pb
fix
cold
aceton
min
presenc
viral
protein
detect
elisa
previous
describ
row
et
al
wall
et
al
polyclon
antibodi
influenza
np
protein
prepar
lab
neutral
end
point
assess
previous
describ
row
et
al
inhibit
ratio
calcul
od
po
control
od
sampl
od
po
control
od
neg
control
